Revere Asset Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,542
Closed -$589K 45
2025
Q4
$589K Buy
+3,542
New +$593K 0.21% 21
2025
Q3
Sell
-7,550
Closed -$683K 42
2025
Q2
$683K Buy
+7,550
New +$597K 0.33% 16
2025
Q1
Sell
-22,523
Closed -$2.98M 29
2024
Q4
$2.98M Buy
+22,523
New +$2.11M 2.53% 11

Other funds holding ALAB

Revere Asset Management's ALAB Position: Q1 2026 in Review

Revere Asset Management sold out of Astera Labs (ALAB) in Q1 2026, closing a stake of 3,542 shares — an estimated $589K sold.

Revere Asset Management first reported a position in ALAB in Q4 2024 and held it in 3 quarters. The position peaked at $2.98M in Q4 2024. 708 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Revere Asset Management reported no remaining Astera Labs position as of Q1 2026 after selling out during the quarter.
  • Revere Asset Management sold 3,542 Astera Labs shares in Q1 2026, an estimated $589K.
  • Revere Asset Management first reported a position in Astera Labs in Q4 2024 and held it in 3 quarters.
  • Revere Asset Management's Astera Labs position peaked at $2.98M in Q4 2024.
  • 708 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Revere Asset Management's 13F filing for Q1 2026, filed 6 May 2026.